Clinical Study of Vorinostat in Combination With Etoposide in Pediatric Patients < 21 Years at Diagnosis With Refractory Solid Tumors
Clinical trial NCT01294670 · COMPLETED
Trial details
- NCT number
- NCT01294670
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-02-09
- Primary completion
- 2020-12-08
- Enrollment
- 27
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.